Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1
- 31 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Basic Research in Cardiology
- Vol. 116 (1), 1-25
- https://doi.org/10.1007/s00395-021-00844-0
Abstract
5-Oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is an arachidonic acid metabolite produced along with leukotrienes via the 5-lipoxygenase pathway. Metabolomics studies have shown that 5-oxo-ETE level is elevated in the serum in acute myocardial infarction (AMI). The actions of 5-oxo-ETE are mediated by the highly selective oxoeicosanoid receptor (OXE-R). Moreover, increased OXE-R content was verified in AMI patients and mice. However, the precise role of OXE-R in AMI is unclear. In the present study, we demonstrate that 5-oxo-ETE triggered myocardial injury in mice. Pathway enrichment analysis identified branched chain amino acid transaminase 1/2 (BCAT1/2) as potential mediators of this effect. Western blot and immunohistochemical analyses showed that BCAT1/BCAT2 expression was significantly reduced by AMI in vitro and in vivo, while pharmacologic inhibition of BCAT1/BCAT2 accelerated myocardial injury. Conversely, heart-specific overexpression of BCAT1/BCAT2 in mice protected against ischemic myocardial injury. Treatment with the selective OXE-R inhibitor Gue1654 alleviated coronary artery ligation-induced ischemic myocardial injury in mice and oxygen/glucose deprivation-induced injury in cardiomyocytes through activation of BCAT1, while inhibiting OXE-R suppressed protein kinase C-epsilon (PKC-epsilon)/nuclear factor kappa B (NF-kappa B) signaling and cardiomyocyte apoptosis. Overall, our study confirmed a novel target OXE-R for the treatment of AMI based on metabolomics, and targeting OXE-R may represent unrecognized therapeutic intervention for cardiovascular diseases through activation of BCAT1.Funding Information
- National Natural Science Foundation of China (81774150, 81973506, 81603328)
This publication has 55 references indexed in Scilit:
- Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular DiseasesCirculation, 2012
- A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimerNature Chemical Biology, 2012
- Hyperlipidaemia induced by a high‐cholesterol diet leads to the deterioration of guanosine‐3′,5′‐cyclic monophosphate/protein kinase G‐dependent cardioprotection in ratsBritish Journal of Pharmacology, 2009
- Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular RiskJournal of the American College of Cardiology, 2009
- The case for regulating indispensable amino acid metabolism: the branched-chain α-keto acid dehydrogenase kinase-knockout mouseBiochemical Journal, 2006
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006
- Metabolomic Identification of Novel Biomarkers of Myocardial IschemiaCirculation, 2005
- 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophilsJournal of Allergy and Clinical Immunology, 2005
- Nuclear Factor-κB Protects the Adult Cardiac Myocyte Against Ischemia-Induced Apoptosis in a Murine Model of Acute Myocardial InfarctionCirculation, 2003
- Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/oOnline Journal of Public Health Informatics, 2002